Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market after the company announced U.S. Food and Drug Administration approval of NEREUS (tradipitant), an oral neurokinin-1 receptor antagonist, for the prevention of motion-induced vomiting in adults.

Vanda Pharmaceuticals shares jumped 17.5% to $8.26 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Aimei Health Technology Co Ltd (NASDAQ:AFJK) surged 61.6% to $133.00 in pre-market trading after jumping 89% on Tuesday.
• Anghami Inc (NASDAQ:ANGH) rose 49.1% to $3.46 in pre-market trading following the release of the company’s six-month results.
• Oriental Rise Holdings Ltd (NASDAQ:ORIS) rose 42.6% to $1.74 in pre-market trading after the company announced a nonbinding letter of intent to acquire a controlling stake in Hubei Daguan Tea Industry Group Co. Ltd., a leading tea producer in Yingshan County, Hubei Province.
• Northann Corp (NYSE:NCL) rose 39.7% to $0.27 in pre-market trading after dipping 15% on Tuesday.
• Inspire Veterinary Partners Inc (NASDAQ:IVP) gained 35.4% to $0.068 in pre-market trading after climbing 18% on Tuesday.
• iSpecimen Inc (NASDAQ:ISPC) rose 29.1% to $0.38 in pre-market trading. The biospecimen marketplace operator announced a $5.5 million private placement with accredited investors.
• Direct Digital Holdings Inc (NASDAQ:DRCT) gained 28.4% to $0.077 in pre-market trading after jumping 12% on Tuesday.
• A SPAC III Acquisition Corp (NASDAQ:ASPC) rose 25% to $34.84 in pre-market trading.
• LI Bang International Corporation Inc (NASDAQ:LBGJ) gained 24.5% to $0.66 in pre-market trading after declining around 13% on Tuesday.

Losers

• Profusa Inc (NASDAQ:PFSA) fell 14.5% to $0.10 in pre-market trading after the company announced the restructuring of its debt and a reduction in potential shareholder dilution, sparking a wave of speculative buying for the digital health company.
• ATIF Holdings Ltd (NASDAQ:ZBAI) fell 12.1% to $5.21 in pre-market trading. ATIF Holdings filed for mixed shelf of up to $500 million.
• Fitell Corp (NASDAQ:FTEL) fell 12.1% to $0.60 in pre-market trading.
• Brenmiller Energy Ltd (NASDAQ:BNRG) dipped 11.8% to $0.54 in pre-market trading after declining 24% on Tuesday.
• Akari Therapeutics PLC (NASDAQ:AKTX) fell 11.1% to $0.24 in pre-market trading.
• Intercont (Cayman) Ltd (NASDAQ:NCT) declined 8.7% to $0.20 in pre-market trading after dipping over 4% on Tuesday.
• Antelope Enterprise Holdings Ltd (NASDAQ:AEHL) dipped 8.3% to $2.00 in pre-market trading after gaining 92% on Tuesday.
• Milestone Scientific Inc (NYSE:MLSS) fell 8.6% to $0.25 in pre-market trading after dipping over 5% on Tuesday.
• Jefferson Capital Inc (NASDAQ:JCAP) shares dipped 7.2% to $21.08 in pre-market trading.
• Cybin Inc (NYSE:CYBN) tumbled 6.6% to $8.00 in pre-market trading. Cybin launched a $100 million at-the-market equity program with Cantor Fitzgerald.

Now Read This:

• Wall Street’s Most Accurate Analysts Give Their Take On 3 Financial Stocks With Over 10% Dividend Yields

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.